Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BeOne
Pharma
Akeso, Summit's ivonescimab ups PD-1 in chemo combo in 1L NSCLC
HARMONi-6 marks the first phase 3 trial in which a regimen has beaten the combination of a PD-1 inhibitor and chemotherapy on PFS in first-line NSCLC.
Angus Liuu
Oct 19, 2025 10:45am
AbbVie, BeOne end BTK inhibitor patent fight
Oct 2, 2025 10:29am
BeOne bags $885M in Royalty deal on Amgen's Imdelltra
Aug 25, 2025 10:34am
BeOne widens BTK lead over AstraZeneca
Aug 6, 2025 10:55am
Akeso's fast-rising ivonescimab scores 3rd lung cancer trial win
Apr 23, 2025 11:30am
BeiGene's Brukinsa surpasses AZ’s Calquence in quarterly sales
Feb 27, 2025 10:56am
